{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:23:28Z","timestamp":1783520608624,"version":"3.55.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12302-y","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:08:59Z","timestamp":1783516139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Campylobacter infection using nano-azurin: innate immune reprogramming and anticancer implications"],"prefix":"10.1007","volume":"53","author":[{"given":"Othman Abdulrahman","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhang Hameed","family":"Awlqadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan Mahmood","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamand Ahmed","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Morya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed N.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"12302_CR1","doi-asserted-by":"publisher","first-page":"52220","DOI":"10.12775\/QS.2024.17.52220","volume":"17","author":"M Nowak","year":"2024","unstructured":"Nowak M, Rak K, K\u0142osowska W, B\u0142aszczyszyn K, Gawe\u0142-D\u0105browska D, Paluch E (2024) Campylobacter: understanding its role as the primary bacterial cause of food-borne illnesses\u2013current state of knowledge. Qual Sport 17:52220\u201352220","journal-title":"Qual Sport"},{"key":"12302_CR2","doi-asserted-by":"publisher","first-page":"979055","DOI":"10.3389\/fcimb.2022.979055","volume":"12","author":"F Liu","year":"2022","unstructured":"Liu F, Lee SA, Xue J, Riordan SM, Zhang L (2022) Global epidemiology of campylobacteriosis and the impact of COVID-19. Front Cell Infect Microbiol 12:979055","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"12302_CR3","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1080\/87559129.2021.1942487","volume":"39","author":"P Myintzaw","year":"2023","unstructured":"Myintzaw P, Jaiswal AK, Jaiswal S (2023) A review on campylobacteriosis associated with poultry meat consumption. Food Reviews Int 39(4):2107\u20132121","journal-title":"Food Reviews Int"},{"issue":"4","key":"12302_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/1541-4337.12544","volume":"19","author":"AB Soro","year":"2020","unstructured":"Soro AB, Whyte P, Bolton DJ, Tiwari BK (2020) Strategies and novel technologies to control Campylobacter in the poultry chain: A review. Compr Rev Food Sci Food Saf 19(4):1353\u20131377","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"12302_CR5","doi-asserted-by":"crossref","unstructured":"Seely KD, Morgan AD, Hagenstein LD, Florey GM, Small JM (2022) Bacterial involvement in progression and metastasis of colorectal neoplasia, Cancers 14(4):1019","DOI":"10.3390\/cancers14041019"},{"issue":"1","key":"12302_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/wjcs.wjcs_19_22","volume":"11","author":"PA Gervaz","year":"2022","unstructured":"Gervaz PA, De Campos \u00c1, Caeiro A (2022) Campylobacter jejuni causes colorectal cancer. World J Colorectal Surg 11(1):4\u20137","journal-title":"World J Colorectal Surg"},{"key":"12302_CR7","doi-asserted-by":"crossref","unstructured":"Lobo de S\u00e1 FD, Schulzke J-D, B\u00fccker R (2021) Diarrheal mechanisms and the role of intestinal barrier dysfunction in Campylobacter infections. In: Backert S (ed) Fighting Campylobacter Infections: Towards a One Health Approach. Current Topics in Microbiol Immuno 431. Springer, Cham, pp 203\u2013231.","DOI":"10.1007\/978-3-030-65481-8_8"},{"issue":"9","key":"12302_CR8","doi-asserted-by":"publisher","first-page":"e24655","DOI":"10.1002\/jcla.24655","volume":"36","author":"D Chinemerem Nwobodo","year":"2022","unstructured":"Chinemerem Nwobodo D et al (2022) Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal 36(9):e24655","journal-title":"J Clin Lab Anal"},{"key":"12302_CR9","doi-asserted-by":"crossref","unstructured":"Murugaiyan J et al (2022) Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics, Antibiotics 11(2):200","DOI":"10.3390\/antibiotics11020200"},{"key":"12302_CR10","doi-asserted-by":"crossref","unstructured":"Alaoui Mdarhri H et al (2022) Alternatives therapeutic approaches to conventional antibiotics: advantages, limitations and potential application in medicine, Antibiotics 11(12):1826","DOI":"10.3390\/antibiotics11121826"},{"issue":"11","key":"12302_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1039\/D1TB02818A","volume":"10","author":"K Li","year":"2022","unstructured":"Li K et al (2022) Targeting the innate immune system with nanoparticles for cancer immunotherapy. J Mater Chem B 10(11):1709\u20131733","journal-title":"J Mater Chem B"},{"key":"12302_CR12","doi-asserted-by":"crossref","unstructured":"Garizo AR, Bernardes N, Chakrabarty AM, Fialho AM (2019) The anticancer potential of the bacterial protein azurin and its derived peptide p28, in Microbial Infections and Cancer Therapy. Jenny Stanford Publishing 319\u2013338","DOI":"10.1201\/9781351041904-9"},{"key":"12302_CR13","doi-asserted-by":"crossref","unstructured":"Omole Z, Dorrell N, Elmi A, Nasher F, Gundogdu O, Wren BW (2024) Pathogenicity and virulence of Campylobacter jejuni: What do we really know? Virulence 15(1):2436060","DOI":"10.1080\/21505594.2024.2436060"},{"key":"12302_CR14","doi-asserted-by":"crossref","unstructured":"Al Hakeem WG, Fathima S, Shanmugasundaram R, Selvaraj RK (2022) Campylobacter jejuni in poultry: Pathogenesis and control strategies, Microorganisms 10(11):2134","DOI":"10.3390\/microorganisms10112134"},{"issue":"9","key":"12302_CR15","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00253-023-12456-w","volume":"107","author":"L Kemper","year":"2023","unstructured":"Kemper L, Hensel A (2023) Campylobacter jejuni: targeting host cells, adhesion, invasion, and survival. Appl Microbiol Biotechnol 107(9):2725\u20132754","journal-title":"Appl Microbiol Biotechnol"},{"key":"12302_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2016.00009","volume":"6","author":"C-K Lai","year":"2016","unstructured":"Lai C-K et al (2016) Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin. Front Cell Infect Microbiol 6:9","journal-title":"Front Cell Infect Microbiol"},{"key":"12302_CR17","doi-asserted-by":"crossref","unstructured":"He Z et al (2024) Campylobacter jejuni-derived cytolethal distending toxin promotes colorectal cancer metastasis. Cell Host Microbe 32(12):2080\u20132091","DOI":"10.1016\/j.chom.2024.11.006"},{"key":"12302_CR18","doi-asserted-by":"crossref","unstructured":"He Z et al (2019) Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin, Gut 68(2):289\u2013300","DOI":"10.1136\/gutjnl-2018-317200"},{"key":"12302_CR19","doi-asserted-by":"crossref","unstructured":"Gabbert AD et al (2023) The missing pieces: the role of secretion systems in Campylobacter jejuni virulence, Biomolecules 13(1):135","DOI":"10.3390\/biom13010135"},{"key":"12302_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3389\/fmicb.2015.00751","volume":"6","author":"J-C Kim","year":"2015","unstructured":"Kim J-C, Oh E, Kim J, Jeon B (2015) Regulation of oxidative stress resistance in Campylobacter jejuni, a microaerophilic foodborne pathogen. Front Microbiol 6:751","journal-title":"Front Microbiol"},{"key":"12302_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jgar.2025.05.008","volume":"43","author":"V Mohan","year":"2025","unstructured":"Mohan V et al (2025) Antimicrobial resistance in Campylobacter spp. focussing on C. jejuni and C. coli\u2013A narrative review. J Global Antimicrob Resist 43:372\u2013389","journal-title":"J Global Antimicrob Resist"},{"key":"12302_CR22","doi-asserted-by":"publisher","first-page":"110675","DOI":"10.1016\/j.enzmictec.2025.110675","volume":"189","author":"NE Al-Hazmi","year":"2025","unstructured":"Al-Hazmi NE et al (2025) Nano-azurin peptide as an inducer of innate immune responses. Enzym Microb Technol 189:110675","journal-title":"Enzym Microb Technol"},{"key":"12302_CR23","unstructured":"Keyhanian K, Mansoori GA, bullet, and, Rahimpour M (2010) Prospects for Cancer Nanotechnology Treatment by Azurin"},{"issue":"2","key":"12302_CR24","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.21608\/ejhm.2022.269978","volume":"89","author":"M Abdallah","year":"2022","unstructured":"Abdallah M et al (2022) Detection of some virulence and antibiotic resistance genes in Campylobacter jejuni isolated from poultry and human. Egypt J Hosp Med 89(2):6373\u20136381","journal-title":"Egypt J Hosp Med"},{"issue":"1","key":"12302_CR25","first-page":"p340605","volume":"2013","author":"K Wieczorek","year":"2013","unstructured":"Wieczorek K, Osek J (2013) Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int 2013(1):p340605","journal-title":"Biomed Res Int"},{"issue":"1","key":"12302_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1556\/EuJMI.2.2012.1.10","volume":"2","author":"H Sprenger","year":"2012","unstructured":"Sprenger H, Zechner EL, Gorkiewicz G (2012) So close and yet so far\u2014molecular microbiology of Campylobacter fetus subspecies. Eur J Microbiol Immunol 2(1):66\u201375","journal-title":"Eur J Microbiol Immunol"},{"issue":"5","key":"12302_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3748\/wjg.v20.i5.1259","volume":"20","author":"L Zhang","year":"2014","unstructured":"Zhang L, Lee H, Grimm MC, Riordan SM, Day AS, Lemberg DA (2014) Campylobacter concisus and inflammatory bowel disease. World J gastroenterology: WJG 20(5):1259","journal-title":"World J gastroenterology: WJG"},{"issue":"4","key":"12302_CR28","doi-asserted-by":"publisher","first-page":"000227","DOI":"10.1099\/acmi.0.000227","volume":"3","author":"PC Tam","year":"2021","unstructured":"Tam PC, Leong LE, Theodossi M, Gordon DL (2021) Intra-abdominal infection with Campylobacter curvus: case report and review of the literature. Access Microbiol 3(4):000227","journal-title":"Access Microbiol"},{"issue":"7","key":"12302_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12275-016-6254-x","volume":"54","author":"S Lee","year":"2016","unstructured":"Lee S et al (2016) Clinical relevance of infections with zoonotic and human oral species of Campylobacter. J Microbiol 54(7):459\u2013467","journal-title":"J Microbiol"},{"key":"12302_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fm.2014.11.017","volume":"48","author":"DJ Bolton","year":"2015","unstructured":"Bolton DJ (2015) Campylobacter virulence and survival factors. Food Microbiol 48:99\u2013108","journal-title":"Food Microbiol"},{"key":"12302_CR31","doi-asserted-by":"crossref","unstructured":"Yamada T et al (2002) Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer, Proceedings of the National Academy of Sciences 99(22):14098\u201314103","DOI":"10.1073\/pnas.222539699"},{"issue":"7","key":"12302_CR32","first-page":"39","volume":"18","author":"C Herl\u00f8v","year":"2022","unstructured":"Herl\u00f8v C, Sloth S, Andersen LP (2022) Colorectal Cancer and Campylobacter rectus, C. showae and C. concisus. EC Microbiol 18(7):39\u201344","journal-title":"EC Microbiol"},{"issue":"9","key":"12302_CR33","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.3390\/ijms26094125","volume":"26","author":"R Tuzhilkin","year":"2025","unstructured":"Tuzhilkin R, Ondru\u0161ka V, \u0160ulc M (2025) Azurin: A Model to Study a Metal Coordination Sphere or Electron Transfer in Metalloproteins. Int J Mol Sci 26(9):4125","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12302_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.febslet.2011.12.014","volume":"586","author":"JJ Warren","year":"2012","unstructured":"Warren JJ, Winkler JR, Gray HB (2012) Redox properties of tyrosine and related molecules. FEBS Lett 586(5):596\u2013602","journal-title":"FEBS Lett"},{"key":"12302_CR35","doi-asserted-by":"crossref","unstructured":"Aslam S et al (2023) Computational Modeling, high-level soluble expression and In vitro cytotoxicity assessment of recombinant Pseudomonas aeruginosa Azurin: a promising anti-cancer therapeutic candidate, Pharmaceutics 15(7):1825","DOI":"10.3390\/pharmaceutics15071825"},{"issue":"1","key":"12302_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s42003-023-04458-1","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu J et al (2023) Structural basis of bacterial effector protein azurin targeting tumor suppressor p53 and inhibiting its ubiquitination. Commun Biology 6(1):59","journal-title":"Commun Biology"},{"key":"12302_CR37","doi-asserted-by":"publisher","unstructured":"Zaghloul NA, Gouda MK, Elbahloul Y, El NM, Halfawy (2025) Azurin a potent anticancer and antimicrobial agent isolated from a novel Pseudomonas aeruginosa strain, (in eng), Sci Rep 15(1):3735 https:\/\/doi.org\/10.1038\/s41598-025-86649-w","DOI":"10.1038\/s41598-025-86649-w"},{"issue":"1","key":"12302_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s42003-022-04395-5","volume":"6","author":"JK Choi","year":"2023","unstructured":"Choi JK et al (2023) Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression. Commun Biology 6(1):16","journal-title":"Commun Biology"},{"key":"12302_CR39","doi-asserted-by":"publisher","unstructured":"Cascella M, Magistrato A, Tavernelli I, Carloni P, Rothlisberger U (2006) Role of protein frame and solvent for the redox properties of azurin from Pseudomonas aeruginosa, (in eng). Proc Natl Acad Sci USA 103(52):19641\u201319646. https:\/\/doi.org\/10.1073\/pnas.0607890103","DOI":"10.1073\/pnas.0607890103"},{"issue":"2","key":"12302_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10930-020-09891-3","volume":"39","author":"F Huang","year":"2020","unstructured":"Huang F et al (2020) Anticancer actions of azurin and its derived peptide p28. Protein J 39(2):182\u2013189","journal-title":"Protein J"},{"key":"12302_CR41","doi-asserted-by":"crossref","unstructured":"Bernardes N, Ribeiro AS, Seruca R, Paredes J, Fialho AM (2011) Bacterial protein azurin as a new candidate drug to treat untreatable breast cancers, in 1st Portuguese Biomedical Engineering Meeting, IEEE, pp. 1\u20134","DOI":"10.1109\/ENBENG.2011.6026047"},{"key":"12302_CR42","doi-asserted-by":"crossref","unstructured":"Atabay M, Sardroodi JJ, Ebrahimzadeh AR, Avestan MS (2022) Modeling the Interaction of Anticancer Protein Azurin with the Nanosheets for Medical Applications, ChemistrySelect 7(47):e202202633","DOI":"10.1002\/slct.202202633"},{"key":"12302_CR43","doi-asserted-by":"publisher","first-page":"139245","DOI":"10.1016\/j.ijbiomac.2024.139245","volume":"300","author":"HM Barzelighi","year":"2025","unstructured":"Barzelighi HM, Bakhshi B, Daraei B, Mirzaei A (2025) Investigating the effect of rAzurin loaded mesoporous silica nanoparticles enwrapped with chitosan-folic acid on breast tumor regression in BALB\/C mice. Int J Biol Macromol 300:139245","journal-title":"Int J Biol Macromol"},{"key":"12302_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.ijbiomac.2014.10.052","volume":"72","author":"M Prabaharan","year":"2015","unstructured":"Prabaharan M (2015) Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol 72:1313\u20131322","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"12302_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12029-021-00654-6","volume":"53","author":"NE Al-Hazmi","year":"2022","unstructured":"Al-Hazmi NE, Naguib DM (2022) Microbial azurin immobilized on nano-chitosan as anticancer and antibacterial agent against gastrointestinal cancers and related bacteria. J Gastrointest Cancer 53(3):537\u2013542","journal-title":"J Gastrointest Cancer"},{"key":"12302_CR46","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.2174\/0113816128275385231027054743","volume":"29 37","author":"L Kumar","year":"2023","unstructured":"Kumar L et al (2023) Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview. Curr Pharm Design 29(37):2940\u20132953","journal-title":"Curr Pharm Design"},{"key":"12302_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ijbiomac.2022.03.121","volume":"208","author":"K Rajendran","year":"2022","unstructured":"Rajendran K, Karthikeyan A, Krishnan UM (2022) Emerging trends in nano-bioactive-mediated mitochondria-targeted therapeutic stratagems using polysaccharides, proteins and lipidic carriers. Int J Biol Macromol 208:627\u2013641","journal-title":"Int J Biol Macromol"},{"key":"12302_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fchem.2018.00237","volume":"6","author":"PM Carvalho","year":"2018","unstructured":"Carvalho PM, Fel\u00edcio MR, Santos NC, Gon\u00e7alves S, Domingues MM (2018) Application of light scattering techniques to nanoparticle characterization and development. Front Chem 6:237","journal-title":"Front Chem"},{"issue":"8","key":"12302_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/jpm11080771","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu J (2021) The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J personalized Med 11(8):771","journal-title":"J personalized Med"},{"issue":"1","key":"12302_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2008.09.016","volume":"139","author":"I Delfino","year":"2009","unstructured":"Delfino I, Cannistraro S (2009) Optical investigation of the electron transfer protein azurin\u2013gold nanoparticle system. Biophys Chem 139(1):1\u20137","journal-title":"Biophys Chem"},{"issue":"23","key":"12302_CR51","doi-asserted-by":"publisher","first-page":"12789","DOI":"10.3390\/ijms222312789","volume":"22","author":"M Malatesta","year":"2021","unstructured":"Malatesta M (2021) Transmission electron microscopy as a powerful tool to investigate the interaction of nanoparticles with subcellular structures. Int J Mol Sci 22(23):12789","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12302_CR52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/applbiosci2040040","volume":"2","author":"LA Linhares","year":"2023","unstructured":"Linhares LA, Ramos CH (2023) Unlocking insights into folding, structure, and function of proteins through circular dichroism spectroscopy\u2014a short review. Appl Biosci 2(4):639\u2013655","journal-title":"Appl Biosci"},{"key":"12302_CR53","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3389\/fonc.2020.01303","volume":"10","author":"A Yaghoubi","year":"2020","unstructured":"Yaghoubi A, Khazaei M, Avan A, Hasanian SM, Cho WC, Soleimanpour S (2020) p28 bacterial peptide, as an anticancer agent. Front Oncol 10:1303","journal-title":"Front Oncol"},{"issue":"2","key":"12302_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/0008-5472.CAN-08-2932","volume":"69","author":"BN Taylor","year":"2009","unstructured":"Taylor BN et al (2009) Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res 69(2):537\u2013546","journal-title":"Cancer Res"},{"issue":"3","key":"12302_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","volume":"172","author":"MJ Ernsting","year":"2013","unstructured":"Ernsting MJ, Murakami M, Roy A, Li S-D (2013) Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Controlled Release 172(3):782\u2013794","journal-title":"J Controlled Release"},{"key":"12302_CR56","doi-asserted-by":"crossref","unstructured":"Bhardwaj R, Mishra P (2023) Multiresponsive nanoscale self-assembly of azurin-elastin-like polypeptide fusion protein for enhanced prostate cancer therapy, Biomacromolecules 25(1):508\u2013521","DOI":"10.1021\/acs.biomac.3c01125"},{"issue":"3","key":"12302_CR57","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3934\/microbiol.2016.3.292","volume":"2","author":"AM Fialho","year":"2016","unstructured":"Fialho AM, Bernardes N, Chakrabarty AM (2016) Exploring the anticancer potential of the bacterial protein azurin. AIMS Microbiol 2(3):292\u2013303","journal-title":"AIMS Microbiol"},{"key":"12302_CR58","doi-asserted-by":"crossref","unstructured":"Yamada T et al (2004) Apoptosis or growth arrest: Modulation of tumor suppressor p53\u2019s specificity by bacterial redox protein azurin, Proceedings of the National Academy of Sciences 101(14):4770\u20134775","DOI":"10.1073\/pnas.0400899101"},{"issue":"11","key":"12302_CR59","doi-asserted-by":"publisher","first-page":"10621","DOI":"10.1021\/acsnano.8b05950","volume":"12","author":"S Singha","year":"2018","unstructured":"Singha S, Shao K, Ellestad KK, Yang Y, Santamaria P (2018) Nanoparticles for immune stimulation against infection, cancer, and autoimmunity. ACS Nano 12(11):10621\u201310635","journal-title":"ACS Nano"},{"key":"12302_CR60","doi-asserted-by":"crossref","unstructured":"Su Y, Gao J, Kaur P, Wang Z (2020) Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases, Pharmaceutics 12(12):1222","DOI":"10.3390\/pharmaceutics12121222"},{"key":"12302_CR61","doi-asserted-by":"publisher","first-page":"621225","DOI":"10.3389\/fimmu.2020.621225","volume":"11","author":"S Gaggero","year":"2021","unstructured":"Gaggero S, Witt K, Carlsten M, Mitra S (2021) Cytokines orchestrating the natural killer-myeloid cell crosstalk in the tumor microenvironment: implications for natural killer cell-based cancer immunotherapy. Front Immunol 11:621225","journal-title":"Front Immunol"},{"issue":"4","key":"12302_CR62","doi-asserted-by":"publisher","first-page":"2350582","DOI":"10.1002\/eji.202350582","volume":"54","author":"A Vaseruk","year":"2024","unstructured":"Vaseruk A, Bila G, Bilyy R (2024) Nanoparticles for stimulation of neutrophil extracellular trap-mediated immunity. Eur J Immunol 54(4):2350582","journal-title":"Eur J Immunol"},{"issue":"12","key":"12302_CR63","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.1128\/IAI.70.12.7054-7062.2002","volume":"70","author":"T Yamada","year":"2002","unstructured":"Yamada T et al (2002) The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect Immun 70(12):7054\u20137062","journal-title":"Infect Immun"},{"issue":"2","key":"12302_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1189\/jlb.0611308","volume":"91","author":"R Wang","year":"2012","unstructured":"Wang R, Jaw JJ, Stutzman NC, Zou Z, Sun PD (2012) Natural killer cell-produced IFN-\u03b3 and TNF-\u03b1 induce target cell cytolysis through up-regulation of ICAM-1. J Leukoc Biol 91(2):299\u2013309","journal-title":"J Leukoc Biol"},{"key":"12302_CR65","doi-asserted-by":"crossref","unstructured":"Vivier E et al (2011) Innate or adaptive immunity? The example of natural killer cells, Science 331(6013):44\u201349","DOI":"10.1126\/science.1198687"},{"issue":"24","key":"12302_CR66","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3390\/ijms262411941","volume":"26","author":"A Ramavat","year":"2025","unstructured":"Ramavat A, Antil P, Kaushik S, Kataria B, Pandey RP (2025) Nanomedicine for Cancer and Autoimmune Immunotherapy. Int J Mol Sci 26(24):11941","journal-title":"Int J Mol Sci"},{"key":"12302_CR67","doi-asserted-by":"crossref","unstructured":"Mu H, Tang J, Liu Q, Sun C, Wang T, Duan J (2016) Potent antibacterial nanoparticles against biofilm and intracellular bacteria, Scientific reports 6(1):18877","DOI":"10.1038\/srep18877"},{"issue":"7","key":"12302_CR68","doi-asserted-by":"publisher","first-page":"e0199974","DOI":"10.1371\/journal.pone.0199974","volume":"13","author":"YM Sierra-Arguello","year":"2018","unstructured":"Sierra-Arguello YM et al (2018) Fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli from poultry and human samples assessed by PCR-restriction fragment length polymorphism assay. PLoS ONE 13(7):e0199974","journal-title":"PLoS ONE"},{"issue":"3","key":"12302_CR69","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/ijms23031112","volume":"23","author":"M Druszczy\u0144ska","year":"2022","unstructured":"Druszczy\u0144ska M, Godkowicz M, Kulesza J, Wawrocki S, Fol M (2022) Cytokine receptors\u2014regulators of antimycobacterial immune response. Int J Mol Sci 23(3):1112","journal-title":"Int J Mol Sci"},{"key":"12302_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cytogfr.2018.03.005","volume":"41","author":"NA Al-Banna","year":"2018","unstructured":"Al-Banna NA, Cyprian F, Albert MJ (2018) Cytokine responses in campylobacteriosis: Linking pathogenesis to immunity. Cytokine Growth Factor Rev 41:75\u201387","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"12302_CR71","doi-asserted-by":"publisher","first-page":"104328","DOI":"10.1016\/j.psj.2024.104328","volume":"103","author":"IA Bundurus","year":"2024","unstructured":"Bundurus IA et al (2024) Mechanistic concepts involved in biofilm associated processes of Campylobacter jejuni: persistence and inhibition in poultry environments. Poult Sci 103(12):104328","journal-title":"Poult Sci"},{"key":"12302_CR72","doi-asserted-by":"publisher","unstructured":"Ding T, Li X, Zhan H, Li Y, Li Z, Deng Y (2026) Quorum sensing: its roles in mediating biofilm and viable but non-culturable state formation, and strategies for the prevention and control of foodborne bacteria via quorum quenching. Food Sci Hum Wellness 15(2). https:\/\/doi.org\/10.26599\/FSHW.2024.9250337","DOI":"10.26599\/FSHW.2024.9250337"},{"key":"12302_CR73","doi-asserted-by":"crossref","unstructured":"Ma Y, Zhu G, Feng L, Jiang S, Xiang Q, Wang J (2023) Efficient cytotoxicity of recombinant Azurin in Escherichia coli Nissle 1917-derived Minicells against colon cancer cells, Bioeng 10(10):1188","DOI":"10.3390\/bioengineering10101188"},{"issue":"1","key":"12302_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12929-025-01161-7","volume":"32","author":"W Gonciarz","year":"2025","unstructured":"Gonciarz W et al (2025) Chitosan-based formulations for therapeutic applications. A recent overview. J Biomed Sci 32(1):62","journal-title":"J Biomed Sci"},{"issue":"1","key":"12302_CR75","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","volume":"22","author":"TTT Vo","year":"2024","unstructured":"Vo TTT et al (2024) The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm. Cell Communication Signal 22(1):353","journal-title":"Cell Communication Signal"},{"key":"12302_CR76","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1080\/15384101.2018.1489178","volume":"17","author":"N Bernardes","year":"2018","unstructured":"Bernardes N et al (2018) Azurin interaction with the lipid raft components ganglioside GM-1 and caveolin-1 increases membrane fluidity and sensitivity to anti-cancer drugs. Cell Cycle 17:1649\u20131666","journal-title":"Cell Cycle"},{"issue":"13","key":"12302_CR77","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.onc.1207376","volume":"23","author":"V Punj","year":"2004","unstructured":"Punj V et al (2004) Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23(13):2367\u20132378","journal-title":"Oncogene"},{"issue":"21","key":"12302_CR78","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1128\/AEM.01390-12","volume":"78","author":"Y Zhang","year":"2012","unstructured":"Zhang Y et al (2012) Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl Environ Microbiol 78(21):7603\u20137610","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"12302_CR79","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10456-011-9220-6","volume":"14","author":"RR Mehta","year":"2011","unstructured":"Mehta RR et al (2011) A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis 14(3):355\u2013369","journal-title":"Angiogenesis"},{"key":"12302_CR80","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL (2021) Cancer immune evasion through loss of MHC class I antigen presentation. Front Immunol 12:636568","journal-title":"Front Immunol"},{"key":"12302_CR81","unstructured":"Joy A, Srivastava A, Biswas R (2024) Azurin-Based Peptide p28 Arrests the p53-HDM2 Interactions: A Novel Anti-Cancer Pathway, arXiv preprint arXiv:2411.07124"},{"key":"12302_CR82","doi-asserted-by":"publisher","first-page":"113660","DOI":"10.1016\/j.jconrel.2025.113660","volume":"382","author":"DB Tran","year":"2025","unstructured":"Tran DB et al (2025) Intracellular redistribution of cell-penetrating peptide p28: A mechanism for enhanced anti-cancer activity. J Controlled Release 382:113660","journal-title":"J Controlled Release"},{"issue":"5","key":"12302_CR83","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/bjc.2013.74","volume":"108","author":"M Warso","year":"2013","unstructured":"Warso M et al (2013) A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours. Br J Cancer 108(5):1061\u20131070","journal-title":"Br J Cancer"},{"key":"12302_CR84","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fgene.2017.00020","volume":"8","author":"P Kalisperati","year":"2017","unstructured":"Kalisperati P et al (2017) Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis. Front Genet 8:20","journal-title":"Front Genet"},{"issue":"2","key":"12302_CR85","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/138920010791110836","volume":"11","author":"Z Cai","year":"2010","unstructured":"Cai Z, Wang Y, Zhu L-j, Liu Z (2010) Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab 11(2):197\u2013207","journal-title":"Curr Drug Metab"},{"key":"12302_CR86","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejca.2021.06.051","volume":"155","author":"F Pham","year":"2021","unstructured":"Pham F, Moinard-Butot F, Coutzac C, Chaput N (2021) Cancer and immunotherapy: a role for microbiota composition. Eur J Cancer 155:145\u2013154","journal-title":"Eur J Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12302-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:02:25Z","timestamp":1783519345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12302-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12302"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12302-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"During the preparation of this work the authors used ChatGPT to simplify some sections. After using this tool\/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"1114"}}